GP Linhao Zhang participated as angel investor in Coherence Neuro's $10M seed round for closed-loop BCI cancer treatment.
NOV 2025
Coherence Neuro designs therapeutic neurotechnology that manages cancer from within the body through its flagship product, SOMA, a brain-computer interface that provides continuous monitoring and targeted bioelectronic therapy
Coherence Neuro designs therapeutic neurotechnology that manages cancer from within the body through its flagship product, SOMA, a brain-computer interface that provides continuous monitoring and targeted bioelectronic therapy.